{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:58:57Z","timestamp":1760299137332,"version":"3.41.2"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.pharep.2015.04.016","type":"journal-article","created":{"date-parts":[[2015,5,9]],"date-time":"2015-05-09T09:45:47Z","timestamp":1431164747000},"page":"1141-1146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Interactions between an antidepressant reboxetine and four classic antiepileptic drugs in the mouse model of myoclonic seizures"],"prefix":"10.1007","volume":"67","author":[{"given":"Monika","family":"Pop\u0142awska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorota","family":"Wr\u00f3blewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kinga K.","family":"Borowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"10.1016\/j.pharep.2015.04.016_bib0175","series-title":"The genetics of neurological disorders","first-page":"96","author":"Baraister","year":"1990"},{"issue":"1A","key":"10.1016\/j.pharep.2015.04.016_bib0180","first-page":"57","article-title":"Depressive disorders in epilepsy","volume":"16","author":"Todorova","year":"2010","journal-title":"J IMAB Annu Proc (Sci Pap)"},{"issue":"2","key":"10.1016\/j.pharep.2015.04.016_bib0185","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1176\/jnp.17.2.172","article-title":"Clinical assessment of Axis I psychiatric morbidity in chronic epilepsy: a multicenter investigation","volume":"17","author":"Jones","year":"2005","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"94","key":"10.1016\/j.pharep.2015.04.016_bib0190","first-page":"337","article-title":"Description of mood disorder in patients with epilepsy","volume":"16","author":"Grabowska-Grzyb","year":"2004","journal-title":"Pol Merkur Lekarski"},{"issue":"3","key":"10.1016\/j.pharep.2015.04.016_bib0195","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1006\/ebeh.2000.0066","article-title":"Comorbid psychiatric symptoms in temporal lobe epilepsy: association with chronicity of epilepsy and impact on quality of life","volume":"1","author":"Hermann","year":"2000","journal-title":"Epilepsy Behav"},{"issue":"5 Suppl. 2","key":"10.1016\/j.pharep.2015.04.016_bib0200","first-page":"S68","article-title":"Seizure risk associated with psychotropic drugs: clinical and pharmacokinetic considerations","volume":"53","author":"Alldredge","year":"1999","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.pharep.2015.04.016_bib0205","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1212\/WNL.37.9.1525","article-title":"Effect of psychotropic medications on seizure control in patients with epilepsy","volume":"37","author":"Ojemann","year":"1987","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.pharep.2015.04.016_bib0210","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1615\/CritRevNeurobiol.v13.i4.10","article-title":"A noradrenergic and serotonergic hypothesis of the linkage between epilepsy and affective disorders","volume":"13","author":"Jobe","year":"1999","journal-title":"Crit Rev Neurobiol"},{"issue":"4","key":"10.1016\/j.pharep.2015.04.016_bib0215","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1527-3458.2003.tb00258.x","article-title":"The promises and pitfalls of reboxetine","volume":"9","author":"Page","year":"2003","journal-title":"CNS Drug Rev"},{"key":"10.1016\/j.pharep.2015.04.016_bib0220","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1002\/(SICI)1099-1077(199802)13:1+<S29::AID-HUP980>3.3.CO;2-4","article-title":"Clinical efficacy of reboxetine: a comparative study with desipramine with methodological considerations","volume":"13","author":"Ben","year":"1998","journal-title":"Hum Psychopharmacol Clin Exp"},{"issue":"3","key":"10.1016\/j.pharep.2015.04.016_bib0225","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.pharep.2013.11.009","article-title":"Reboxetine and its influence on the action of classical antiepileptic drugs in the mouse maximal electroshock model","volume":"66","author":"Borowicz","year":"2014","journal-title":"Pharmacol Rep"},{"issue":"Suppl. 8","key":"10.1016\/j.pharep.2015.04.016_bib0230","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/epi.12027","article-title":"Current position of phenobarbital in epilepsy and its future","volume":"53","author":"Brodie","year":"2012","journal-title":"Epilepsia"},{"issue":"9","key":"10.1016\/j.pharep.2015.04.016_bib0235","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.seizure.2009.06.009","article-title":"Isobolographic characterization of the anticonvulsant interaction profiles of levetiracetam in combination with clonazepam, ethosuximide, phenobarbital and valproate in the mouse pentylenetetrazole-induced seizure model","volume":"18","author":"Dudra-Jastrz\u0119bska","year":"2009","journal-title":"Seizure"},{"issue":"5","key":"10.1016\/j.pharep.2015.04.016_bib0240","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/sj.npp.1300602","article-title":"Pharmacological and behavioral characteristics of interactions between vigabatrin and conventional antiepileptic drugs in pentylenetetrazole-induced seizures in mice: an isobolographic analysis","volume":"30","author":"\u0141uszczki","year":"2005","journal-title":"Neuropsychopharmacology"},{"year":"1971","series-title":"Probit analysis","author":"Finney","key":"10.1016\/j.pharep.2015.04.016_bib0245"},{"issue":"2","key":"10.1016\/j.pharep.2015.04.016_bib0250","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-3565(25)03549-9","article-title":"A simplified method of evaluating dose\u2013effect experiments","volume":"96","author":"Litchfield","year":"1949","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharep.2015.04.016_bib0255","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000134913","article-title":"A new method for exploration the activity of \u201ctranqullizers\u201d: the chimney test (French)","volume":"3","author":"Boissier","year":"1960","journal-title":"Med Exp (Basel)"},{"issue":"6073","key":"10.1016\/j.pharep.2015.04.016_bib0260","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/321864a0","article-title":"Benzodiazedines impair and beta-carbolines enhance performance in learning and memory tasks","volume":"321","author":"Venault","year":"1986","journal-title":"Nature (London)"},{"issue":"8","key":"10.1016\/j.pharep.2015.04.016_bib0265","first-page":"289","article-title":"Seizures associated with antidepressants: a review","volume":"54","author":"Rosenstein","year":"1993","journal-title":"J Clin Psychiatry"},{"issue":"Suppl. 4","key":"10.1016\/j.pharep.2015.04.016_bib0270","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0006-3223(03)00469-4","article-title":"Depression in epilepsy: prevalence, clinical semiology, pathogenic mechanism and treatment","volume":"54","author":"Kanner","year":"2003","journal-title":"Biol Psychiatry"},{"issue":"4","key":"10.1016\/j.pharep.2015.04.016_bib0275","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/sj.npp.1300847","article-title":"The effects of chronic norepinephrine transporter inactivation on seizure susceptibility in mice","volume":"31","author":"Ahern","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.pharep.2015.04.016_bib0280","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/j.1528-1167.2012.03436.x","article-title":"The antidepressants citalopram and reboxetine reduce seizure frequency in rats with chronic epilepsy","volume":"53","author":"Vermoesen","year":"2012","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.pharep.2015.04.016_bib0285","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/ana.410180611","article-title":"Acute effects of antidepressants on hippocampal seizures","volume":"18","author":"Clifford","year":"1985","journal-title":"Ann Neurol"},{"issue":"7","key":"10.1016\/j.pharep.2015.04.016_bib0290","first-page":"1053","article-title":"Anticonvulsant action of GBR-12909 and citalopram against acute experimentally induced limbic seizures","volume":"47","author":"Clinckers","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"24","key":"10.1016\/j.pharep.2015.04.016_bib0295","doi-asserted-by":"crossref","first-page":"10985","DOI":"10.1523\/JNEUROSCI.19-24-10985.1999","article-title":"Norepinephrine-deficient mice have increased susceptibility to seizure-inducing stimuli","volume":"19","author":"Szot","year":"1999","journal-title":"J Neurosci"},{"issue":"4","key":"10.1016\/j.pharep.2015.04.016_bib0300","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.yebeh.2005.07.014","article-title":"The serotonergic and noradrenergic effects of antidepressant drugs are anticonvulsant, not proconvulsant","volume":"7","author":"Jobe","year":"2005","journal-title":"Epilepsy Behav"},{"issue":"1","key":"10.1016\/j.pharep.2015.04.016_bib0305","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1155\/NP.1994.65","article-title":"Effects of intraventricular locus coeruleus transplants on seizure severity in genetically epilepsy-prone rats following depletion of brain norepinephrine","volume":"5","author":"Clough","year":"1994","journal-title":"J Neural Transplant Plast"},{"issue":"5","key":"10.1016\/j.pharep.2015.04.016_bib0310","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.neubiorev.2004.06.008","article-title":"The role of norepinephrine in epilepsy: from the bench to the bedside","volume":"28","author":"Giorgi","year":"2004","journal-title":"Neurosci Biobehav Rev"},{"issue":"3","key":"10.1016\/j.pharep.2015.04.016_bib0315","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0163-7258(02)00218-8","article-title":"The role of catecholamines in seizure susceptibility: new results using genetically engineered mice","volume":"94","author":"Weinshenker","year":"2002","journal-title":"Pharmacol Ther"},{"issue":"12","key":"10.1016\/j.pharep.2015.04.016_bib0320","doi-asserted-by":"crossref","first-page":"941","DOI":"10.2165\/00023210-200115120-00004","article-title":"Third-generation antidepressants: do they offer advantages over the SSRIs?","volume":"15","author":"Olver","year":"2001","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.pharep.2015.04.016_bib0325","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00131746-200401000-00006","article-title":"a norepinephrine selective reuptake pump inhibitor","volume":"10","author":"Preskorn","year":"2004","journal-title":"J Psychiatr Pract"},{"issue":"6","key":"10.1016\/j.pharep.2015.04.016_bib0330","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.yebeh.2003.08.009","article-title":"Antidepressive treatment in patients with temporal lobe epilepsy and major depression: a prospective study with three different antidepressants","volume":"4","author":"K\u00fchn","year":"2003","journal-title":"Epilepsy Behav"},{"issue":"2","key":"10.1016\/j.pharep.2015.04.016_bib0335","first-page":"E147","article-title":"The efficacy of reboxetine as an antidepressant, a meta-analysis of both continuous (mean HAM-D score) and dichotomous (response rate) outcomes","volume":"54","author":"Chuluunkhuu","year":"2008","journal-title":"Kobe J Med Sci"},{"key":"10.1016\/j.pharep.2015.04.016_bib0340","doi-asserted-by":"crossref","first-page":"c4737","DOI":"10.1136\/bmj.c4737","article-title":"Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials","volume":"341","author":"Eyding","year":"2010","journal-title":"BMJ"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114015000857?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114015000857?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:36:04Z","timestamp":1752611764000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2015.04.016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S1734114015000857"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2015.04.016","relation":{},"ISSN":["1734-1140"],"issn-type":[{"type":"print","value":"1734-1140"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interactions between an antidepressant reboxetine and four classic antiepileptic drugs in the mouse model of myoclonic seizures","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2015.04.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.","name":"copyright","label":"Copyright"}]}}